Invasive Pneumococcal Disease in New Zealand, 2010

More documents

Recommendations

Info

3.7 Risk factors among IPD casesThe risk factors reported among IPD cases in 2010 are recorded in Table 6. Risk factors forthe subset of 37 cases
3.8 Immunisation status of casesAmong the 40 cases that were vaccine eligible, that is, those born after 1 January 2008, 35were recorded as having ≥1 dose of PCV-7 before the onset of their disease (Table 7).Among the 34 cases who had had ≥1 dose of PCV-7, and for whom the serotype causingdisease was known, 27 (79.4%) had IPD due to a non-PCV-7 type. Of the seven cases whohad received ≥1 dose of PCV-7 and had disease due to a PCV-7 type, five had serotype 19Fdisease, one had type 6B disease and one had type 14 disease.The immunisation status of three of the four asplenic cases was recorded. The ages of thesecases ranged from 48-97 years, and none was reported to be immunised with a pneumococcalvaccine.Table 7. PCV-7 immunisation status of the 2010 invasive pneumococcal disease caseswho were born after 1 January 2008 1Number ofdoses receivedprior to onset ofIPD 2Cases due to aPCV-7 typen=10Number (%) of casesCases due to anon-PCV-7 typen=29All casesn=40 30 3 (30.0) 2 (6.9) 5 (12.5)1 3 (30.0) 4 2 (6.9) 5 (12.5)2 1 (10.0) 5 4 (13.8) 5 (12.5)3 3 (30.0) 6 14 (48.3) 18 3 (45.0)4 0 7 (24.1) 7 (10.0)1 All infants born after 1 January 2008 are eligible for PCV-7 immunisation.2 If onset date not reported, notification date used.3 The serotype of one case is not known.4 All three cases were due to serotype 19F.5 Case due to serotype 6B.6 Two cases due to serotype 19F and one to serotype 14.Invasive pneumococcal disease 13 September 2011in NZ, 2010
Page 1 and 2: INVASIVE PNEUMOCOCCAL DISEASEIN NEW
Page 3 and 4: DISCLAIMERThis report or document (
Page 5 and 6: CONTENTSSUMMARY ...................
Page 7 and 8: SUMMARYA 4-dose schedule of the 7-v
Page 9 and 10: 1. INTRODUCTIONPrior to 2009, the n
Page 11 and 12: Data analyses were performed with S
Page 13 and 14: 3. RESULTSIn 2010, 535 IPD cases we
Page 15 and 16: The all-age rate of IPD in 2010 (12
Page 17: 3.4 Disease incidence by ethnicityT
Page 23 and 24: 3.10 Serotype distributionTable 9.
Page 25 and 26: Rate per 100 000The rate of disease
Page 27 and 28: 3.11 Antimicrobial susceptibilityTa
Page 29 and 30: Percent of penicillin-resistant iso
Page 31 and 32: type most frequently reported to ha
Page 33 and 34: REFERENCES1 Green MJ, Cawley PFM. I
Page 35 and 36: Appendix 1. Laboratory criteria upo
Page 37 and 38: Appendix 3. Rates of invasive pneum
Page 39 and 40: Appendix 5.2010Risk factors among i
Page 41 and 42: Appendix 7. Serotypes among invasiv
Page 43 and 44: Appendix 9. Serotype 1 invasive pne
Page 45 and 46: Appendix 11. Trends in penicillin r
Page 47 and 48: Appendix 13. Penicillin and cefotax
Page 49: Appendix 15. Trends in penicillin r

Invasive Pneumococcal Disease in New Zealand, 2010

Create successful ePaper yourself

Delete template?

Save as template?